All Carl Zeiss Meditec articles
-
News briefsCarl Zeiss Meditec acquires DORC
Regulators having cleared the way, Carl Zeiss Meditec has finished acquiring the Dutch Ophthalmic Research Center (DORC). Negotiations began in December of last year. The seller is Eurazeo, an investment firm headquartered in Paris. The terms of the deal remain undisclosed, but Eurazeo reports the following: “The transaction has generated ...
-
News briefsSlight revenue growth and lower margins for Carl Zeiss Meditec in Q1
Carl Zeiss Meditec Q1 revenue inched up by 1.0 percent year-on-year to €475 million, corresponding to a 3.3 percent increase at constant exchange rates. The slight topline growth was driven by the Microsurgery division, where quarterly sales reached €124 million, up by 13.7 percent in constant currencies versus Q1 2022/23. ...
-
News briefs
Topcon settles U.S. lawsuit with Carl Zeiss Meditec
Japanese-based equipment maker Topcon has announced that it would incur an extraordinary loss of 3,341 million Japanese yen (€21 m) to settle a lawsuit filed against its U.S. subsidiaries, Topcon Medical Systems and Topcon Healthcare Solutions, by Carl Zeiss Meditec. According to the German company’s statement, Topcon U.S. branches made ...
-
ArticleDouble-digit sales growth but lower margin in full year for Carl Zeiss Meditec
Carl Zeiss Meditec has reported a 9.8 percent year-on-year increase in revenue to €2,089 for its full fiscal year ended Sept. 30. In constant currencies, the topline was up by 10.1 percent with market share gains in both business units - ophthalmic devices and microsurgery. The company stressed that it ...
-
News briefs
Strong sales but margins remain under pressure at Carl Zeiss Meditec
Carl Zeiss Meditec has reported a 12.9 percent year-on-year growth in revenue at constant rates for the first nine months of this year, totaling €1,510 million. Sales of ophthalmology equipment reached €1,152 million, up by 11.8 percent compared with 2022, and the microsurgery unit also reported a double-digit hike. Geographically ...
-
News briefs
Carl Zeiss Meditec adjusts profit outlook slightly down
Carl Zeiss Meditec Q2 revenues increased by 13.2 percent year-on-year to €504 million but the company’s operating profit (EBIT) for the period went down to €84 million, versus €103 million for Q2 2021. For the first half of the fiscal year, EBIT went down by 18.8 percent to €144 million. ...
-
ArticleZEISS Vision Care advocates carefulness over speed in myopia management
ZEISS Vision Care, which has been active in myopia management (MM) clinical research in Asia for over ten years and has been marketing specific lenses in the region since 2011, is launching the category in Europe this spring, a couple of years after its main lens competitors entered the segment ...
-
News briefs
Carl Zeiss Meditec reports strong sales growth but lower margins for Q1
Carl Zeiss Meditec revenues increased by 14.6 percent year-on-year in Q1 2022/23 to €470.3 million, or by 12.1 percent in constant currencies, in spite of ongoing supply chain issues for both its business units. At constant exchange rates and compared with Q1 2021/22, sales in the Ophthalmology division went up ...
-
ArticleCarl Zeiss Meditec ends year with 15 % topline growth and full order book
Carl Zeiss Meditec has reported annual revenue of €1,903 million for its 2021/22 fiscal year, an increase of 15.5 percent in reported terms and of 13.3 percent at constant exchange rates compared to the previous year. Orders received increased at an even faster pace (27.7 percent in constant currencies) to ...
-
News briefs
Double-digit revenue and order intake growth for Carl Zeiss Meditec
Carl Zeiss Meditec has reported a 10 percent year-on-year increase at constant exchange rates in sales of ophthalmic devices to €1,027 million for the first nine months of its current fiscal year. The division’s growth was once again driven by recurring revenue from consumables, implants and services while sales of ...
-
News briefs
Carl Zeiss Meditec slowed down by supply chain hiccups
Carl Zeiss Meditec reported revenues of €855.4 million for the first six months of its 2021/22 financial year, up by 11.5 percent in reported terms and by 10.7 percent in constant currencies from H1 2020/21. The Ophthalmic Devices division posted sales of €651.9 million, up by 9.7 percent year-on-year at ...
-
News briefs
Q1 revenues up at Carl Zeiss Meditec
Carl Zeiss Meditec reported revenues of €410.2 million for the first three months of its 2021/22 financial year, up by 11.2 percent in reported terms and by 10.5 percent in constant currencies from the previous first quarter’s €368.9 million. Sales in the Ophtalmic Devices unit grew year-on-year by 9.7 percent ...
-
News briefs
Record revenues for Carl Zeiss Meditec in 2020/21
Carl Zeiss Meditec posted record revenues of €1,647 million for its full 2020/21 fiscal year, growing by 23.3 percent year-on-year in reported terms and by 26.5 percent in constant currencies. The growth was driven by the Ophtalmic Devices unit where sales jumped by 29.8 percent year-on-year and at constant exchange ...
-
News briefs
Change at the helm of Carl Zeiss Meditec
ZEISS announced last week that Dr. Ludwin Monz, president and CEO of Carl Zeiss Meditec, has decided to step down from the executive board of the group’s ophthalmic devices and microsurgery subsidiary. Monz, whose term will end at the end of this year, has been at the helm of Carl ...
-
News briefs
Carl Zeiss Meditec revenues and margins up double-digit
Carl Zeiss Meditec reported revenues of €1,198 million for the first nine months of its 2020/21 financial year, growing by 23.8 percent year-on-year in reported terms and by 27.6 percent in constant currencies. As compared with the 2018/19 fiscal year, 9-month revenues were up by 16.6 percent. The growth ...
-
ArticleCarl Zeiss Meditec sees Covid-19 impact fading
Providing more details on its H1 2020/21 performance after an initial announcement at the end of April, Carl Zeiss Meditec confirmed a 7.3 percent year-on-year hike in total revenues to €767.4 million. On a constant currency basis, sales increased by 10.5 percent. The growth in revenues was driven ...
-
News briefs
Strong rebound for Carl Zeiss Meditec
Carl Zeiss Meditec announced that its H1 revenues increased by 7.3 percent year-on-year to €767.4 million, or by 10.5 percent in constant currencies. The growth was particularly strong in the second quarter where comparable sales jumped by 18.8 percent as compared to the same quarter in the previous year. ...
-
News briefs
Carl Zeiss Meditec revenues back to pre-Covid levels in Q1
Carl Zeiss Meditec ’s revenues for the first quarter of its 2020/21 financial year reached €368.9 million, down by 0.2 percent year-on-year in reported terms but up by 2.6 percent after adjustment of currency effects. The overall topline recovery was fueled by the good performance of the Ophthalmic Devices’ business ...
-
News briefs
Carl Zeiss Meditec warns that Covid will continue hit results
Carl Zeiss Meditec posted revenues of €1,336 million in the fiscal year ended in September, down by 8.5 percent year-over-year on a reported basis and by 8.7 percent when adjusted for currency effects. The performance of the German medical technology company was affected by the Covid-19 pandemic. It warned ...
